Bryhali (halobetasol propionate)

pCPA File Number: 21910
Negotiation Status:
Concluded with an LOI
Indication(s):
Corticosteroid-Responsive Dermatoses and The Topical Treatment of Plaque Psoriasis
Sponsor/Manufacturer:
Bausch Health, Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: